Clinical interest of combining transcriptomic and genomic signatures in high-grade serous ovarian cancer

HIGHLIGHTS

• who: Fatima Mechta-Grigoriou from the Institut Curie, Stress and Laboratory, Equipe labelisée Ligue Nationale Contre le, PSL University, Department Surgery, Institut Curie Hospital Group, René Huguenin Hospital, Saint-Cloud, France have published the Article: Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer, in the Journal: AOCS
• what: The authors demonstrate that among the four transcriptomic signatures analyzed (Tothill et_al, 2008; Cancer Genome and Atlas Research, 2011; Mateescu et_al, 2011; Bentink et_al, 2012; Verhaak et_al, 2013), patient stratification into two subgroups, defined as the Fibrosis/non-Fibrosis signature . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.